|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2002-8-14
|
|
pubmed:abstractText |
The cisplatin and gemcitabine (GC) regimen is usually administered as a 4- or 3-week schedule; however, the best schedule to use is still unclear. We therefore started a randomized phase II trial to compare toxicity and dose intensity (DI) between these two GC schedules.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1080-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12176787-Adult,
pubmed-meshheading:12176787-Aged,
pubmed-meshheading:12176787-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12176787-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12176787-Cisplatin,
pubmed-meshheading:12176787-Confidence Intervals,
pubmed-meshheading:12176787-Deoxycytidine,
pubmed-meshheading:12176787-Dose-Response Relationship, Drug,
pubmed-meshheading:12176787-Drug Administration Schedule,
pubmed-meshheading:12176787-Female,
pubmed-meshheading:12176787-Follow-Up Studies,
pubmed-meshheading:12176787-Humans,
pubmed-meshheading:12176787-Lung Neoplasms,
pubmed-meshheading:12176787-Male,
pubmed-meshheading:12176787-Maximum Tolerated Dose,
pubmed-meshheading:12176787-Middle Aged,
pubmed-meshheading:12176787-Neoplasms,
pubmed-meshheading:12176787-Reference Values,
pubmed-meshheading:12176787-Survival Analysis,
pubmed-meshheading:12176787-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.
|
|
pubmed:affiliation |
Department of Medical Oncology and Hematology and Division of Thoracic Surgery, Istituto Clinico Humanitas, Rozzano-Milan, Italy. hector.sotoparra@humanitas.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
